Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading AXSM News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.50%176.960.4%$170.90m
PRGOPerrigo Co. Plc
-0.03%73.996.4%$144.57m
VRXValeant Pharmaceuticals International, Inc.
-1.39%9.2514.2%$140.56m
ALRAlere Inc.
0.12%49.162.7%$137.07m
UTHRUnited Therapeutics Corporation
4.32%125.7013.9%$97.54m
JAZZJazz Pharmaceuticals Plc
-1.69%159.282.2%$89.92m
MDCOMedicines Company
1.52%49.3222.5%$75.86m
ENDPEndo International Plc
0.80%11.378.9%$73.90m
MNKMallinckrodt Plc
1.16%46.9216.8%$69.52m
HZNPHorizon Pharma plc
-0.71%15.387.6%$41.04m
ICLRICON Plc
1.59%84.494.1%$35.05m
ICPTIntercept Pharmaceuticals, Inc.
-0.78%112.3522.3%$34.59m
PRXLPAREXEL International Corporation
0.73%63.837.9%$33.77m
PCRXPacira Pharmaceuticals, Inc.
1.04%48.5510.9%$31.50m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.25%118.737.6%$28.29m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.